Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

ClinicalTrials.gov ID: NCT06502366

Public ClinicalTrials.gov record NCT06502366. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-controlled, Double-blind, Multicenter, 12-Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared With BDA Delivered by MDI HFA in Participants With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed replacement propellant HFO compared with BDA delivered using the currently approved propellant HFA in participants with asthma.

Study identification

NCT ID
NCT06502366
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
424 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2024 (Actual)
Primary completion
Apr 17, 2026 (Actual)
Completion
Apr 17, 2026 (Actual)
Last update posted
Sep 8, 2026

2024 – 2026

United States locations

U.S. sites
70
U.S. states
31
U.S. cities
69
Facility City State ZIP Site status
Research Site Mobile Alabama 36608 —
Research Site Sheffield Alabama 35660 —
Research Site Phoenix Arizona 85018 —
Research Site Little Rock Arkansas 72205 —
Research Site Encinitas California 92024 —
Research Site Fullerton California 92835 —
Research Site Gardena California 90247 —
Research Site Huntington Beach California 92647 —
Research Site La Mesa California 91942 —
Research Site Los Angeles California 90025 —
Research Site Los Angeles California 90048 —
Research Site Sacramento California 95821 —
Research Site San Bernardino California 92408 —
Research Site San Diego California 92123 —
Research Site San Jose California 95117 —
Research Site Santa Ana California 92704 —
Research Site Stockton California 95207 —
Research Site Westminster California 92683 —
Research Site Englewood Colorado 80110 —
Research Site Wheat Ridge Colorado 80033 —
Research Site Washington D.C. District of Columbia 20016 —
Research Site Boynton Beach Florida 33435 —
Research Site Miami Florida 33175 —
Research Site Tallahassee Florida 32308 —
Research Site Tampa Florida 33607 —
Research Site Atlanta Georgia 30328 —
Research Site Rincon Georgia 31326 —
Research Site Savannah Georgia 31406 —
Research Site Meridian Idaho 83646 —
Research Site River Forest Illinois 60305 —
Research Site Evansville Indiana 47715 —
Research Site Valparaiso Indiana 46383 —
Research Site Sioux City Iowa 51106 —
Research Site Louisville Kentucky 40217 —
Research Site Lafayette Louisiana 70508 —
Research Site New Orleans Louisiana 70119 —
Research Site White Marsh Maryland 21162 —
Research Site Flint Michigan 48504 —
Research Site Columbia Missouri 65203 —
Research Site St Louis Missouri 63141 —
Research Site Omaha Nebraska 68134 —
Research Site Monticello New York 12701 —
Research Site New York New York 10036 —
Research Site Watertown New York 13601 —
Research Site Charlotte North Carolina 28273 —
Research Site Raleigh North Carolina 27607 —
Research Site Cincinnati Ohio 45236 —
Research Site Oklahoma City Oklahoma 73120 —
Research Site Tulsa Oklahoma 74136 —
Research Site Medford Oregon 97504 —
Research Site Portland Oregon 97202 —
Research Site Pottstown Pennsylvania 19464 —
Research Site Scottdale Pennsylvania 15683 —
Research Site Greenville South Carolina 29615 —
Research Site North Charleston South Carolina 29420 —
Research Site Boerne Texas 78006 —
Research Site Dallas Texas 75231 —
Research Site DeSoto Texas 75115 —
Research Site El Paso Texas 79924 —
Research Site Kingwood Texas 77339 —
Research Site McKinney Texas 75069 —
Research Site Pearland Texas 77584 —
Research Site San Antonio Texas 78258 —
Research Site Victoria Texas 77901 —
Research Site West Jordan Utah 84088 —
Research Site Burke Virginia 22015 —
Research Site Portsmouth Virginia 23703 —
Research Site Spokane Washington 99218 —
Research Site Morgantown West Virginia 26505 —
Research Site Milwaukee Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06502366, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06502366 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →